Long-term conservative management of symptomatic bladder endometriosis: A case series of 17 patients

Objectives: This study aimed to evaluate the course of long-term conservative management of bladder endometriosis (BE). Materials and methods: We retrospectively reviewed 17 cases of BE conservatively managed without surgery in our facility. The following factors were analyzed: age, medical history,...

Full description

Bibliographic Details
Main Authors: Natsuki Nagashima, Tetsuya Hirata, Tomoko Arakawa, Kazuaki Neriishi, Hui Sun, Miyuki Harada, Yasushi Hirota, Kaori Koga, Osamu Wada-Hiraike, Yutaka Osuga
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Taiwanese Journal of Obstetrics & Gynecology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1028455922001425
_version_ 1828311196591194112
author Natsuki Nagashima
Tetsuya Hirata
Tomoko Arakawa
Kazuaki Neriishi
Hui Sun
Miyuki Harada
Yasushi Hirota
Kaori Koga
Osamu Wada-Hiraike
Yutaka Osuga
author_facet Natsuki Nagashima
Tetsuya Hirata
Tomoko Arakawa
Kazuaki Neriishi
Hui Sun
Miyuki Harada
Yasushi Hirota
Kaori Koga
Osamu Wada-Hiraike
Yutaka Osuga
author_sort Natsuki Nagashima
collection DOAJ
description Objectives: This study aimed to evaluate the course of long-term conservative management of bladder endometriosis (BE). Materials and methods: We retrospectively reviewed 17 cases of BE conservatively managed without surgery in our facility. The following factors were analyzed: age, medical history, lesion size, symptoms, hormonal treatment, and follow-up outcomes. Results: In this study, 15 patients received hormonal therapy and 2 did not. Oral contraceptive (OC), dienogest (DNG), and gonadotropin-releasing hormone agonist (GnRHa) were administered as the first regimen in 7, 5, and 3 patients, respectively. Of the 7 patients, OC administration was effective in alleviating urinary symptoms in all but 2 patients. Of 3 patients who received GnRHa, 2 switched to OC and then DNG, and 1 patient discontinued the treatment because of adverse effects. Of 5 patients who received DNG, all experienced symptom relief. DNG, OC, and GnRHa administration were effective and tolerable in 9 of 10 patients (90.0%), in 5 of 9 patients (55.6%), and in 2 of 3 patients (66.7%), respectively. In particular, 3 patients completed DNG treatment until menopause. The size of the BE lesion significantly decreased after 3 months of DNG administration, and the reduction effect was maintained until 48 months thereafter. Conclusion: This study proposed that hormonal therapy for BE is an effective option for those who are not planning to conceive or to undergo surgery. Specifically, DNG may be suitable for patients refusing surgery, considering the effectiveness and tolerance for long-term use.
first_indexed 2024-04-13T15:55:39Z
format Article
id doaj.art-cc4bac5dc597416ab9fb8148ffcfc352
institution Directory Open Access Journal
issn 1028-4559
language English
last_indexed 2024-04-13T15:55:39Z
publishDate 2022-07-01
publisher Elsevier
record_format Article
series Taiwanese Journal of Obstetrics & Gynecology
spelling doaj.art-cc4bac5dc597416ab9fb8148ffcfc3522022-12-22T02:40:43ZengElsevierTaiwanese Journal of Obstetrics & Gynecology1028-45592022-07-01614606611Long-term conservative management of symptomatic bladder endometriosis: A case series of 17 patientsNatsuki Nagashima0Tetsuya Hirata1Tomoko Arakawa2Kazuaki Neriishi3Hui Sun4Miyuki Harada5Yasushi Hirota6Kaori Koga7Osamu Wada-Hiraike8Yutaka Osuga9Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, JapanDepartment of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, Japan; Department of Obstetrics and Gynecology, Doai Kinen Hospital, Japan; Corresponding author. Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. Fax: +81 3 3816-2017.Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, JapanDepartment of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, JapanDepartment of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, JapanDepartment of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, JapanDepartment of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, JapanDepartment of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, JapanDepartment of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, JapanDepartment of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, JapanObjectives: This study aimed to evaluate the course of long-term conservative management of bladder endometriosis (BE). Materials and methods: We retrospectively reviewed 17 cases of BE conservatively managed without surgery in our facility. The following factors were analyzed: age, medical history, lesion size, symptoms, hormonal treatment, and follow-up outcomes. Results: In this study, 15 patients received hormonal therapy and 2 did not. Oral contraceptive (OC), dienogest (DNG), and gonadotropin-releasing hormone agonist (GnRHa) were administered as the first regimen in 7, 5, and 3 patients, respectively. Of the 7 patients, OC administration was effective in alleviating urinary symptoms in all but 2 patients. Of 3 patients who received GnRHa, 2 switched to OC and then DNG, and 1 patient discontinued the treatment because of adverse effects. Of 5 patients who received DNG, all experienced symptom relief. DNG, OC, and GnRHa administration were effective and tolerable in 9 of 10 patients (90.0%), in 5 of 9 patients (55.6%), and in 2 of 3 patients (66.7%), respectively. In particular, 3 patients completed DNG treatment until menopause. The size of the BE lesion significantly decreased after 3 months of DNG administration, and the reduction effect was maintained until 48 months thereafter. Conclusion: This study proposed that hormonal therapy for BE is an effective option for those who are not planning to conceive or to undergo surgery. Specifically, DNG may be suitable for patients refusing surgery, considering the effectiveness and tolerance for long-term use.http://www.sciencedirect.com/science/article/pii/S1028455922001425Bladder endometriosisHormonal treatmentDienogestLong-term management
spellingShingle Natsuki Nagashima
Tetsuya Hirata
Tomoko Arakawa
Kazuaki Neriishi
Hui Sun
Miyuki Harada
Yasushi Hirota
Kaori Koga
Osamu Wada-Hiraike
Yutaka Osuga
Long-term conservative management of symptomatic bladder endometriosis: A case series of 17 patients
Taiwanese Journal of Obstetrics & Gynecology
Bladder endometriosis
Hormonal treatment
Dienogest
Long-term management
title Long-term conservative management of symptomatic bladder endometriosis: A case series of 17 patients
title_full Long-term conservative management of symptomatic bladder endometriosis: A case series of 17 patients
title_fullStr Long-term conservative management of symptomatic bladder endometriosis: A case series of 17 patients
title_full_unstemmed Long-term conservative management of symptomatic bladder endometriosis: A case series of 17 patients
title_short Long-term conservative management of symptomatic bladder endometriosis: A case series of 17 patients
title_sort long term conservative management of symptomatic bladder endometriosis a case series of 17 patients
topic Bladder endometriosis
Hormonal treatment
Dienogest
Long-term management
url http://www.sciencedirect.com/science/article/pii/S1028455922001425
work_keys_str_mv AT natsukinagashima longtermconservativemanagementofsymptomaticbladderendometriosisacaseseriesof17patients
AT tetsuyahirata longtermconservativemanagementofsymptomaticbladderendometriosisacaseseriesof17patients
AT tomokoarakawa longtermconservativemanagementofsymptomaticbladderendometriosisacaseseriesof17patients
AT kazuakineriishi longtermconservativemanagementofsymptomaticbladderendometriosisacaseseriesof17patients
AT huisun longtermconservativemanagementofsymptomaticbladderendometriosisacaseseriesof17patients
AT miyukiharada longtermconservativemanagementofsymptomaticbladderendometriosisacaseseriesof17patients
AT yasushihirota longtermconservativemanagementofsymptomaticbladderendometriosisacaseseriesof17patients
AT kaorikoga longtermconservativemanagementofsymptomaticbladderendometriosisacaseseriesof17patients
AT osamuwadahiraike longtermconservativemanagementofsymptomaticbladderendometriosisacaseseriesof17patients
AT yutakaosuga longtermconservativemanagementofsymptomaticbladderendometriosisacaseseriesof17patients